Management of Alcohol Intoxication

Assessment and Initial Management of Acute Alcohol Intoxication

The American College of Physicians recommends thiamine supplementation (oral or parenteral) to prevent Wernicke's encephalopathy in patients with severe intoxication 1, 2

Management of Alcohol Withdrawal

Benzodiazepines are the front-line medication for alcohol withdrawal to alleviate discomfort and prevent seizures and delirium, according to the American Medical Association 1, 2, 3
Antipsychotics should not be used as stand-alone medications but may be used as adjuncts to benzodiazepines in severe withdrawal delirium that has not responded to adequate doses of benzodiazepines, as suggested by the American Psychiatric Association 1, 3
All patients should receive oral thiamine; high-risk patients (malnourished, severe withdrawal) or those with suspected Wernicke's encephalopathy should receive parenteral thiamine, recommends the National Institute of Health 1, 2

Inpatient vs. Outpatient Management

Patients at risk of severe withdrawal, with concurrent serious physical or psychiatric disorders, or lacking adequate support should be managed in an inpatient setting, advises the American Hospital Association 1, 2
Patients can be safely discharged when they have stable vital signs, resolution of withdrawal symptoms (CIWA-Ar score <8), no complications requiring inpatient care, and a comprehensive follow-up plan, according to the American Medical Association 4

Long-term Management and Relapse Prevention

Acamprosate, disulfiram, or naltrexone should be offered to reduce relapse in alcohol-dependent patients, recommends the National Institute on Alcohol Abuse and Alcoholism 1, 2, 3
Psychosocial support should be routinely offered to alcohol-dependent patients, advises the American Psychological Association 1, 2
Non-specialist healthcare workers should encourage engagement with mutual help groups like Alcoholics Anonymous, suggests the American Medical Association 1, 2

Common Pitfalls and Special Considerations

Overlooking concurrent substance use disorders that may complicate recovery is a common pitfall, warns the Substance Abuse and Mental Health Services Administration 4
Prescribing benzodiazepines for longer than necessary (beyond 7-14 days), increasing dependence risk, is a potential mistake, cautions the American College of Physicians 4

Management of Alcohol Intoxication

Initial Assessment and Stabilization

Management decisions should be based on the patient's cognitive abilities and clinical presentation rather than waiting for a specific blood alcohol level, as recommended by the American College of Emergency Physicians 5, 6
Psychiatric evaluation can proceed in alert, cooperative patients with normal vital signs and noncontributory history/physical examination, regardless of elevated alcohol levels, according to the American College of Emergency Physicians 5

Observation Period and Disposition

A period of observation should be used to determine if psychiatric symptoms resolve as intoxication resolves, as suggested by the American College of Emergency Physicians 5, 6
Alcohol intoxication can mimic or alter psychiatric symptoms, and suicidality often diminishes as blood alcohol concentration decreases, as noted by the American College of Emergency Physicians 5, 6

Critical Pitfalls to Avoid

Routine toxicologic screening should not be ordered in alert, cooperative patients with noncontributory history/physical examination and normal vital signs, as studies show no justified change in management plans and only 20% sensitivity for organic etiology, according to the American College of Emergency Physicians 5, 6
Psychiatric evaluation should not be delayed waiting for blood alcohol concentration results if the patient demonstrates adequate cognition, alertness, and normal vital signs, as recommended by the American College of Emergency Physicians 5, 6

Management of Alcohol Use Disorder

Pharmacotherapy for Abstinence Maintenance

The British Medical Journal recommends acamprosate as the only intervention with high-quality evidence showing superiority over placebo for maintaining abstinence in detoxified, alcohol-dependent patients 7, 8
The Liver International journal suggests that medications such as naltrexone or disulfiram should be initiated after acute withdrawal resolves, not during the first 3 months when mortality is primarily related to hepatitis severity rather than relapse 9

Psychosocial Support

The Liver International journal recommends brief interventions, such as 15-minute personalized counseling, as effective in primary care for reducing excessive consumption in non-dependent drinkers 10
The British Medical Journal suggests that failing to provide medium-to-long-term support after initial detoxification can lead to relapse, as abstinence maintenance requires ongoing care 8

Management of Acute Alcohol Intoxication

Initial Assessment and Stabilization

The American College of Emergency Physicians recommends basing management decisions on the patient's cognitive abilities and clinical presentation rather than waiting for a specific blood alcohol level, and proceeding with psychiatric evaluation in alert, cooperative patients with normal vital signs regardless of elevated alcohol levels 11
The American College of Emergency Physicians emphasizes that cognitive abilities—not a specific blood alcohol level—should determine when to begin psychiatric assessment and disposition planning 11
Assess cognitive function individually rather than relying on predetermined blood alcohol concentrations, including evaluating mental status such as alertness, orientation, memory, judgment, and decision-making capacity 11

Critical Pitfalls to Avoid

Do not delay psychiatric evaluation waiting for blood alcohol results if the patient demonstrates adequate cognition, alertness, and normal vital signs, as there is no evidence-based blood alcohol concentration threshold at which psychiatric evaluation can accurately commence 11
Recognize that alcohol intoxication can mimic or alter psychiatric symptoms, and suicidality often diminishes as blood alcohol concentration decreases, and use an observation period to reassess as intoxication resolves 11

Management of Alcohol Intoxication and Withdrawal

Pharmacological Management

The American Association for the Study of Liver Diseases recommends benzodiazepines as the gold standard treatment for alcohol withdrawal syndrome, given their efficacy to reduce withdrawal symptoms and prevent seizures and delirium tremens, with long-acting benzodiazepines (diazepam, chlordiazepoxide) providing superior protection against seizures and delirium 12, 13
The American Association for the Study of Liver Diseases suggests that short/intermediate-acting benzodiazepines (lorazepam, oxazepam) are safer in elderly patients and those with hepatic dysfunction 12, 13
The European Association for the Study of the Liver recommends acamprosate as a pharmacotherapy option for maintaining abstinence in detoxified, alcohol-dependent patients, with a dose of 1,998 mg/day for patients ≥60 kg, reduced by one-third for <60 kg, for 3-6 months 14
The American Heart Association notes that complete abstinence from alcohol is essential where there is suspected correlation between alcohol intake and complications 15
Naltrexone can be used for relapse prevention, but is not recommended in patients with alcoholic liver disease due to hepatotoxicity risk 13, 14
Disulfiram should be avoided in patients with severe alcoholic liver disease because of possible hepatotoxicity 13
Baclofen shows promise for maintaining abstinence by reducing alcohol craving, particularly in patients with liver cirrhosis 14

Evidence-Based Management of Alcohol Use Disorder

Thiamine Supplementation

Thiamine deficiency affects 30-80% of alcohol-dependent patients due to malnutrition and impaired absorption, according to the American Association for the Study of Liver Diseases 16
The American College of Gastroenterology recommends thiamine supplementation to prevent Wernicke's encephalopathy, which is difficult to diagnose in critical care settings 16, 17

Benzodiazepines for Alcohol Withdrawal

The American College of Gastroenterology suggests using short-acting benzodiazepines (oxazepam or lorazepam) in patients with liver disease (cirrhosis) to avoid drug accumulation and encephalopathy risk 16, 17
Over 70% of cirrhotic patients do not require benzodiazepines for withdrawal, and symptom-adapted dosing is preferred over fixed-schedule dosing, as recommended by the American Association for the Study of Liver Diseases 17

Long-Term Pharmacotherapy for Abstinence Maintenance

Naltrexone can be used for relapse prevention in patients without severe liver disease, according to the American Medical Association 16
Acamprosate is safe and effective for maintaining abstinence in patients with and without severe liver disease, as recommended by the American College of Gastroenterology 16
Baclofen (up to 80 mg/day) is safe and shows promise for maintaining abstinence, particularly in cirrhotic patients, according to the American Association for the Study of Liver Diseases 16

Smoking Cessation and Abstinence Goals in Alcohol Dependence

Smoking Cessation for Patients with Alcohol Dependence

Offer smoking‑cessation programs to all individuals receiving treatment for alcohol dependence, because concurrent tobacco use is highly prevalent and raises the risk of oropharyngeal cancers. 18

Therapeutic Goal of Complete Abstinence

Aim for complete abstinence from alcohol as the primary therapeutic objective, especially in patients who have developed alcohol‑related physical complications. 18